{"id":"86a754c6-f41a-4165-86e6-6c5b110ef5ab","slug":"fda-510k-cmr-versius-plus-clearance","kind":"regulatory_action","headline":"FDA clears CMR Surgical Versius Plus robotic surgical system for gallbladder removal procedures","summary":"CMR Surgical secured FDA 510(k) clearance for its Versius Plus minimally invasive robotic surgical system, indicated for gallbladder removal procedures. The modular system can be moved between hospital departments. CMR plans US commercialization in 2026, following a $200M equity and debt investment in April 2026.","occurredAt":"2026-07-01T00:00:00.000Z","reviewStatus":"unreviewed","modelId":null,"deploymentId":null,"companyId":"6bbb447e-0278-4ae1-822d-8b546420511e","aliases":[],"collisionRisk":"none","reviewNote":null,"severity":"minor","rootCauseCategory":null,"rootCauseDetail":null,"affectedUnitsCount":null,"affectedUnitsBasis":null,"remediationStatus":null,"regulatoryAction":"other","regulatoryBody":"FDA","propertyDamageEstimateUsd":null,"damageEstimateBasis":null,"bodilyInjurySeverity":null,"fatalityCount":null,"lossCostClass":null,"sourceQualityTier":null,"oshaRecordable":null,"oshaCaseNumber":null,"rootCauseDisclosed":null,"publicDisclosureDate":null,"insuranceClaimPublic":null,"formFactor":null,"latitude":null,"longitude":null,"autonomyClass":null,"legalOutcomeClass":"unknown","createdAt":"2026-07-23T14:06:14.374Z","updatedAt":"2026-07-23T14:06:14.374Z","model":null,"deployment":null,"company":{"id":"6bbb447e-0278-4ae1-822d-8b546420511e","name":"CMR Surgical","slug":"cmr-surgical","description":"UK surgical-robotics company (Cambridge; founded 2014) making the Versius modular multi-arm teleoperated surgical robot; FDA De Novo 2024 + Versius Plus 510(k) 2025; >40k procedures ex-US.","status":"private (recapitalized $200M+ Apr 2025; current valuation unconfirmed)","founded":2014,"hq":"Cambridge, United Kingdom","fundingTotal":null,"type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.globenewswire.com/news-release/2024/10/15/cmr-surgical-versius-fda-de-novo","title":"CMR Surgical receives US FDA De Novo for Versius (cholecystectomy; Oct 2024)","sourceName":"CMR Surgical (GlobeNewswire)"},{"url":"https://www.therobotreport.com/cmr-surgical-receives-fda-clearance-for-versius-plus-surgical-robot/","title":"CMR Surgical FDA 510(k) for Versius Plus (Dec 18 2025; US launch 2026)","sourceName":"The Robot Report"},{"url":"https://www.massdevice.com/cmr-surgical-200-million-funding/","title":"CMR Surgical raises $200M+ to fund US/Asia commercialization (Apr 2025)","sourceName":"MassDevice"},{"url":"https://www.globenewswire.com/news-release/2026/03/17/cmr-surgical-nvidia-igx-thor","title":"CMR Surgical + NVIDIA IGX Thor (evaluating AI for next-gen Versius; R&D-stage)","sourceName":"CMR Surgical (GlobeNewswire)"}],"keyFacts":[{"label":"Product","value":"Versius / Versius Plus modular multi-arm teleoperated surgical robot."},{"label":"Gating events","value":"FDA De Novo Oct 2024; Versius Plus 510(k) Dec 2025; gynecology 510(k) pending."},{"label":"wikidata","value":"https://www.wikidata.org/wiki/Q60775579"},{"label":"wikipedia","value":"https://en.wikipedia.org/wiki/CMR_Surgical"},{"label":"Founded","value":"2014, Cambridge, UK"},{"label":"Key product","value":"Versius surgical robot system"},{"label":"FDA clearance","value":"Versius Plus secured"}],"aliases":["CMR","Cambridge Medical Robotics","Versius"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-03T20:12:28.328Z","updatedAt":"2026-07-08T03:25:33.274Z"},"derived":{"status":"active"},"sources":[{"id":"67e3c63e-1fc9-4da2-af08-3421319af54a","incidentId":"86a754c6-f41a-4165-86e6-6c5b110ef5ab","url":"https://www.medicaldevice-network.com/news/fda-clears-cmr-surgical-versius-plus-robot/","label":"Medical Device Network","publishedAt":"2026-07-01T00:00:00.000Z","notes":null,"title":null,"sourceName":"Medical Device Network","mediaType":"article","videoId":null,"channel":null,"durationSec":null,"timestampSec":null,"createdAt":"2026-07-23T14:06:14.374Z","updatedAt":"2026-07-23T14:06:14.374Z"}],"responses":[],"statusEvents":[{"id":"17493f3f-702b-4849-8884-96f1ce31b44b","incidentId":"86a754c6-f41a-4165-86e6-6c5b110ef5ab","status":"active","reason":null,"source":"agent:recon","effectiveAt":"2026-07-23T14:06:15.712Z","createdAt":"2026-07-23T14:06:15.712Z"}],"jsonLd":{"@context":"https://schema.org","@type":"NewsArticle","@id":"https://registry.deploy.report/incidents/fda-510k-cmr-versius-plus-clearance","url":"https://registry.deploy.report/incidents/fda-510k-cmr-versius-plus-clearance","headline":"FDA clears CMR Surgical Versius Plus robotic surgical system for gallbladder removal procedures","description":"CMR Surgical secured FDA 510(k) clearance for its Versius Plus minimally invasive robotic surgical system, indicated for gallbladder removal procedures. The modular system can be moved between hospital departments. CMR plans US commercialization in 2026, following a $200M equity and debt investment in April 2026.","identifier":"86a754c6-f41a-4165-86e6-6c5b110ef5ab","datePublished":"2026-07-01T00:00:00.000Z","articleSection":"regulatory action","publisher":{"@id":"https://deploy.report/#organization"},"author":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"unreviewed","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":[]}}}